HHS Secretary Tom Price calls for health IT that works for clinicians and better interoperability.
An analysis of claims data found that an off-label settlement for one Eli Lilly drug did not significantly change how often it was prescribed off-label after the settlements.
Researchers found that DTC advertising was associated with significant increases in testing and treatment for these drugs
Organizations are focusing on better ways to verify HCPs’ digital identities.
About 30% of patients are more likely to fill a prescription after being exposed to healthcare ads at the point of care, according to Kantar Media.
Please login or register first to view this content.